Company Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Equities
IL0011042806
Investment Holding Companies
Business Summary
Sales per Business
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 132 | 100.0 % | 18 | 100.0 % | -86.35% |
Sales per region
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 132 | 100.0 % | 18 | 100.0 % | -86.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 15-06-30 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-12-31 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | 70 | 07-05-14 | |
Iris Sadeh
AUD | Comptroller/Controller/Auditor | - | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 03-05-08 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 15-11-17 |
Gad Keren
BRD | Director/Board Member | 73 | 20-02-16 |
Gabriel Barbash
BRD | Director/Board Member | 74 | 03-03-24 |
Director/Board Member | 39 | 17-12-04 | |
Nufar Malovani
BRD | Director/Board Member | 46 | 17-11-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 161,256,549 | 55,870,242 ( 34.65 %) | 4,410,349 ( 2.735 %) | 34.65 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GAMIDA CELL LTD. 1.95% | 2,581,746 | 1.95% | 92,943 $ |
Company contact information
Clal Biotechnology Industries Ltd.
Triangle Building Azrieli Center 3
67023, Tel Aviv
+
http://www.cbi.co.ilSector
1st Jan change | Capi. | |
---|---|---|
+17.11% | 75.59B | |
+58.67% | 16.95B | |
+3.89% | 15.78B | |
+8.12% | 13.87B | |
-0.31% | 12.3B | |
+9.49% | 12.04B | |
+6.40% | 10.88B | |
+37.06% | 10.17B | |
-1.50% | 9.7B |